» Articles » PMID: 18053157

Impacts of Chronic Kidney Disease and Albuminuria on Associations Between Coronary Heart Disease and Its Traditional Risk Factors in Type 2 Diabetic Patients - the Hong Kong Diabetes Registry

Overview
Publisher Biomed Central
Date 2007 Dec 7
PMID 18053157
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Glycated haemoglobin (HbA1c), blood pressure and body mass index (BMI) are risk factors for albuminuria, the latter in turn can lead to hyperlipidaemia. We used novel statistical analyses to examine how albuminuria and chronic kidney disease (CKD) may influence the effects of other risk factors on coronary heart disease (CHD).

Methods: A prospective cohort of 7067 Chinese type 2 diabetic patients without history of CHD enrolled since 1995 were censored on July 30th, 2005. Cox proportional hazard regression with restricted cubic spline was used to auto-select predictors. Hazard ratio plots were used to examine the risk of CHD. Based on these plots, non-linear risk factors were categorised and the categorised variables were refitted into various Cox models in a stepwise manner to confirm the findings.

Results: Age, male gender, duration of diabetes, spot urinary albumin: creatinine ratio, estimated glomerular filtration rate, total cholesterol (TC), high density lipoprotein cholesterol (HDL-C) and current smoking status were risk factors of CHD. Linear association between TC and CHD was observed only in patients with albuminuria. Although in general, increased HDL-C was associated with decreased risk of CHD, full-range HDL-C was associated with CHD in an A-shaped manner with a zenith at 1.1 mmol/L. Albuminuria and CKD were the main contributors for the paradoxically positive association between HDL-C and CHD for HDL-C values less than 1.1 mmol/L.

Conclusion: In type 2 diabetes, albuminuria plays a linking role between conventional risk factors and CHD. The onset of CKD changes risk associations between lipids and CHD.

Citing Articles

Frail hypertensive older adults with prediabetes and chronic kidney disease: insights on organ damage and cognitive performance - preliminary results from the CARYATID study.

Santulli G, Visco V, Ciccarelli M, Ferrante M, De Masi P, Pansini A Cardiovasc Diabetol. 2024; 23(1):125.

PMID: 38600564 PMC: 11007948. DOI: 10.1186/s12933-024-02218-x.


Precision prognostics for cardiovascular disease in Type 2 diabetes: a systematic review and meta-analysis.

Ahmad A, Lim L, Morieri M, Tam C, Cheng F, Chikowore T Commun Med (Lond). 2024; 4(1):11.

PMID: 38253823 PMC: 10803333. DOI: 10.1038/s43856-023-00429-z.


Microalbuminuria and Hypertension among Immigrants with Type 2 Diabetes: A Community-Based Cross-Sectional Study.

Sukhram S, Zarini G, Shaban L, Vaccaro J, Huffman F J Pers Med. 2022; 12(11).

PMID: 36579508 PMC: 9697914. DOI: 10.3390/jpm12111777.


Diabetic kidney disease and risk of incident stroke among adults with type 2 diabetes.

Kaze A, Jaar B, Fonarow G, Echouffo-Tcheugui J BMC Med. 2022; 20(1):127.

PMID: 35346165 PMC: 8962078. DOI: 10.1186/s12916-022-02317-0.


Microvascular disease and cardiovascular outcomes among individuals with type 2 diabetes.

Kaze A, Santhanam P, Erqou S, Bertoni A, Ahima R, Echouffo-Tcheugui J Diabetes Res Clin Pract. 2021; 176:108859.

PMID: 33989668 PMC: 8627586. DOI: 10.1016/j.diabres.2021.108859.


References
1.
Wanner C, Krane V, Marz W, Olschewski M, Mann J, Ruf G . Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. N Engl J Med. 2005; 353(3):238-48. DOI: 10.1056/NEJMoa043545. View

2.
Murray C, Lopez A . Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet. 1997; 349(9061):1269-76. DOI: 10.1016/S0140-6736(96)07493-4. View

3.
Nissen S, Tardif J, Nicholls S, Revkin J, Shear C, Duggan W . Effect of torcetrapib on the progression of coronary atherosclerosis. N Engl J Med. 2007; 356(13):1304-16. DOI: 10.1056/NEJMoa070635. View

4.
Laakso M . Cardiovascular disease in type 2 diabetes: challenge for treatment and prevention. J Intern Med. 2001; 249(3):225-35. DOI: 10.1046/j.1365-2796.2001.00789.x. View

5.
Turner R, Millns H, Neil H, Stratton I, Manley S, Matthews D . Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23). BMJ. 1998; 316(7134):823-8. PMC: 28484. DOI: 10.1136/bmj.316.7134.823. View